Amantadine for treatment of fatigue in Guillain‐Barré syndrome: a randomised, double blind, placebo controlled, crossover trial

OBJECTIVE: Fatigue is a major complaint in patients with immune mediated polyneuropathies. Despite apparently good physical recovery after Guillain‐Barré syndrome (GBS), many patients remain restricted in daily and social activities, and have a decreased quality of life. In this trial, the effect of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garssen, M P J, Schmitz, P I M, Merkies, I S J, Jacobs, B C, van der Meché, F G A, van Doorn, P A
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2117395/
https://ncbi.nlm.nih.gov/pubmed/16361594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2004.046227
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars